ChoA Pharmaceutical Co., LTD. (KOSDAQ:034940)
South Korea
· Delayed Price · Currency is KRW 1,084.00
+11.00 (1.03%)
At close: Jul 14, 2025, 3:30 PM KST
KOSDAQ:034940 Revenue
ChoA Pharmaceutical Co., LTD. had revenue of 14.37B KRW in the quarter ending March 31, 2025, a decrease of -5.04%. This brings the company's revenue in the last twelve months to 61.93B, down -0.53% year-over-year. In the year 2024, ChoA Pharmaceutical Co., LTD. had annual revenue of 62.69B, down -0.44%.
Revenue (ttm)
61.93B
Revenue Growth
-0.53%
P/S Ratio
0.56
Revenue / Employee
247.72M
Employees
250
Market Cap
34.39B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 62.69B | -280.00M | -0.44% |
| Dec 31, 2023 | 62.97B | -5.91B | -8.57% |
| Dec 31, 2022 | 68.88B | 11.32B | 19.66% |
| Dec 31, 2021 | 57.56B | -7.80B | -11.93% |
| Dec 31, 2020 | 65.36B | -2.18B | -3.22% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Electronics | 308.10T |
| SK hynix | 71.40T |
| LG Energy Solution | 25.76T |
| Samsung Biologics | 4,898.69B |
| Hyundai Motor Company | 178.98T |
| KB Financial Group | 14.93T |
| Celltrion | 3,662.23B |
| Kia Corporation | 109.25T |